X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28085) 28085
Newsletter (2262) 2262
Newspaper Article (484) 484
Magazine Article (304) 304
Book Chapter (295) 295
Dissertation (120) 120
Publication (110) 110
Transcript (27) 27
Conference Proceeding (26) 26
Book / eBook (14) 14
Streaming Video (13) 13
Web Resource (11) 11
Reference (10) 10
Book Review (6) 6
Government Document (3) 3
Journal / eJournal (1) 1
Pamphlet (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19591) 19591
warfarin (17672) 17672
science & technology (14710) 14710
life sciences & biomedicine (14287) 14287
male (10407) 10407
female (9965) 9965
warfarin - therapeutic use (8997) 8997
aged (7353) 7353
anticoagulants - therapeutic use (7209) 7209
middle aged (6909) 6909
anticoagulants (5477) 5477
warfarin - adverse effects (5403) 5403
warfarin - administration & dosage (5154) 5154
atrial fibrillation (4976) 4976
anticoagulants - adverse effects (4659) 4659
adult (4528) 4528
cardiovascular system & cardiology (4528) 4528
anticoagulants - administration & dosage (4440) 4440
abridged index medicus (4261) 4261
risk factors (3810) 3810
stroke (3241) 3241
aged, 80 and over (2952) 2952
cardiac & cardiovascular systems (2950) 2950
atrial fibrillation - drug therapy (2867) 2867
research (2761) 2761
international normalized ratio (2726) 2726
pharmacology & pharmacy (2685) 2685
general & internal medicine (2667) 2667
treatment outcome (2659) 2659
medicine, general & internal (2461) 2461
care and treatment (2166) 2166
hematology (2157) 2157
hemorrhage - chemically induced (2138) 2138
peripheral vascular disease (2128) 2128
warfarin - pharmacology (2110) 2110
atrial fibrillation - complications (2105) 2105
retrospective studies (2097) 2097
stroke - prevention & control (2081) 2081
animals (2056) 2056
administration, oral (2051) 2051
thromboembolism (1996) 1996
drug therapy (1932) 1932
drug interactions (1850) 1850
anticoagulation (1827) 1827
analysis (1825) 1825
time factors (1660) 1660
thrombosis (1610) 1610
dosage and administration (1606) 1606
health aspects (1552) 1552
medical research (1483) 1483
aspirin (1413) 1413
thromboembolism - prevention & control (1403) 1403
aspirin - therapeutic use (1373) 1373
patients (1373) 1373
medicine, experimental (1361) 1361
heparin - therapeutic use (1350) 1350
prothrombin time (1316) 1316
prevention (1310) 1310
surgery (1292) 1292
follow-up studies (1240) 1240
bleeding (1228) 1228
medicine & public health (1224) 1224
stroke - etiology (1221) 1221
hemorrhage (1196) 1196
dose-response relationship, drug (1163) 1163
cardiac arrhythmia (1161) 1161
prospective studies (1124) 1124
dabigatran (1119) 1119
complications and side effects (1039) 1039
adolescent (1032) 1032
blood coagulation - drug effects (1023) 1023
anticoagulants - pharmacology (999) 999
drug therapy, combination (995) 995
rivaroxaban (988) 988
usage (982) 982
mortality (979) 979
cardiology (970) 970
risk assessment (963) 963
rats (945) 945
cardiovascular diseases (943) 943
warfarin - pharmacokinetics (912) 912
heparin (899) 899
pharmacogenetics (890) 890
warfarin - metabolism (887) 887
platelet aggregation inhibitors - therapeutic use (881) 881
neurosciences & neurology (862) 862
vitamin k (861) 861
drugs (833) 833
thrombin (826) 826
warfarin - blood (807) 807
internal medicine (792) 792
clinical trials (762) 762
clinical neurology (758) 758
cohort studies (739) 739
incidence (720) 720
venous thrombosis - drug therapy (714) 714
fibrinolytic agents - therapeutic use (701) 701
anticoagulants - pharmacokinetics (697) 697
genotype (693) 693
pregnancy (687) 687
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30289) 30289
Japanese (667) 667
Spanish (174) 174
Russian (173) 173
German (155) 155
Portuguese (155) 155
French (150) 150
Chinese (115) 115
Italian (98) 98
Czech (88) 88
Swedish (87) 87
Norwegian (71) 71
Turkish (65) 65
Korean (43) 43
Danish (33) 33
Polish (22) 22
Finnish (20) 20
Hebrew (19) 19
Hungarian (16) 16
Slovak (12) 12
Dutch (9) 9
Persian (6) 6
Croatian (5) 5
Bulgarian (4) 4
Afrikaans (3) 3
Romanian (3) 3
Serbian (3) 3
Slovenian (3) 3
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Revisado Agosto de 2008, AHRQ pub., Volume no. 08-0028-B
eBook
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 02/2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Index Medicus | Abridged Index Medicus | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2012, Volume 107, Issue 3, pp. 561 - 569
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2018, Volume 319, Issue 12, p. 1278
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2013, Volume 369, Issue 15, pp. 1406 - 1415
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2013, Volume 369, Issue 22, pp. 2093 - 2104
Journal Article